![](https://www.discoverx.com/content/uploads/2023/05/COVID-19_Small-Card-Image-310x174.jpg)
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreShowing 1–12 of 27 results
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreReady-to-use kits for biologics characterization, MOA confirmation, NAbs detection, stability studies, & potency testing
Read MoreProgram designed to qualify CRO/CDMOs to run Eurofins DiscoverX bioassays for client downstream therapeutic efforts
Read MoreStable cell lines, cell pools, frozen cells, & primary effector cells for a broad range of target classes
Read MoreAccelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors
Read MoreHighly purified, pre-validated reference ligands & inhibitors for use with Eurofins DiscoverX cell lines
Read MoreCustom cell lines, kits, assays, & protein development capabilities optimized to fit your requirements
Read MoreComprehensive portfolio of cell-based, functional assays for cytokines & interleukin receptors
Read MoreSimple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death
Read MoreFluorescent assays to measure calcium mobilization in cell lines as a direct indication of GPCR or ion channel activation or…
Read MoreUniversal G-protein independent cell-based assays to quantify GPCR activation based on the recruitment of β-arrestin
Read More